Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Treatment of chronic hepatitis B].
Asselah T, Lada O, Boyer N, Martinot M, Marcellin P. Asselah T, et al. Among authors: lada o. Gastroenterol Clin Biol. 2008 Aug-Sep;32(8-9):749-68. doi: 10.1016/j.gcb.2008.07.001. Epub 2008 Sep 4. Gastroenterol Clin Biol. 2008. PMID: 18775613 Free article. Review. French.
[Treatment "à la carte" of chronic hepatitis B].
Marcellin P, Asselah T, Lada O. Marcellin P, et al. Among authors: lada o. Gastroenterol Clin Biol. 2008 Jan;32(1 Pt 2):S1-5. doi: 10.1016/S0399-8320(08)73258-5. Gastroenterol Clin Biol. 2008. PMID: 18662604 Free article. French. No abstract available.
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P. Martinot-Peignoux M, et al. Among authors: lada o. J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16. J Clin Virol. 2013. PMID: 24004660
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Laouénan C, Marcellin P, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Peytavin G, Mentré F, Guedj J. Laouénan C, et al. Among authors: lada o. Antimicrob Agents Chemother. 2014 Sep;58(9):5332-41. doi: 10.1128/AAC.02611-14. Epub 2014 Jun 30. Antimicrob Agents Chemother. 2014. PMID: 24982076 Free PMC article. Clinical Trial.
Interferon therapy for chronic hepatitis B.
Asselah T, Lada O, Moucari R, Martinot M, Boyer N, Marcellin P. Asselah T, et al. Among authors: lada o. Clin Liver Dis. 2007 Nov;11(4):839-49, viii. doi: 10.1016/j.cld.2007.08.010. Clin Liver Dis. 2007. PMID: 17981231 Review.
30 results